SAXONOV SERGE (Chief Executive Officer) sold 1.0% of their position (10.49K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $667.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/28/2026ACC: 0001610717-26-000393
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2019
-10.49K
Net shares
Net seller
$667.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10.49K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
−3.50K
Price / share
$63.02
Trade value
$220.58K
% of position
0.3%
8/26/2026
1.09M→1.08M
Class A Common Stock
Direct
Shares
−6.49K
Price / share
$63.98
Trade value
$415.47K
% of position
0.6%
8/26/2026
1.08M→1.08M
Class A Common Stock
Direct
Shares
−492.00
Price / share
$64.75
Trade value
$31.86K
% of position
0.0%
8/26/2026
1.08M→1.08M
Total
Net shares
−10.49K
Net value
-$667.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/26/2026 | S · Sale | −3.50K | $63.02 | $220.58K | 0.3% | 1.09M | 1.08M |
| Class A Common Stock Direct | 8/26/2026 | S · Sale | −6.49K | $63.98 | $415.47K | 0.6% | 1.08M | 1.08M |
| Class A Common Stock Direct | 8/26/2026 | S · Sale | −492.00 | $64.75 | $31.86K | 0.0% | 1.08M | 1.08M |
| Total | −10.49K | -$667.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Class A Common Stock
IndirectShares owned71.64K
Class A Common Stock
IndirectShares owned27.00
Class A Common Stock
IndirectShares owned213.25K
Total
284.92K indirect284.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 71.64K | Indirect |
| Class A Common Stock | 27.00 | Indirect |
| Class A Common Stock | 213.25K | Indirect |
| Total | 284.92K | 284.92K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported